Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-04-11-Speech-2-271"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-04-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Deliberate release into the environment of GMOs2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20000411.10.2-271"2
lpv:hasSubsequent	lp_eu:2000-04-11-Speech-2-2722
lpv:speaker	lp:Antonios Trakatellis2
lpv:spokenAs	substitute; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 member_of_the_bureau; EPP-ED (2000-04-10--2004-07-19)3 member; PETI (1999-07-21--2000-09-03)3 substitute; Delegation to the EU-Cyprus Joint Parliamentary Committee (1999-10-08--2002-01-14)3 member; Delegation for relations with Israel (1999-10-06--2002-01-14)3 unknown; Nea Dimokratia (1999-07-20--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3
lpv:translated text	"Mr President, there has been a significant increase in biotechnology applications and they are becoming more and more important both to the economy and to society, because using applications derived from genetically-modified organisms will be instrumental in improving our quality of life. Hence, it is essential that we introduce a modern framework governing the development, marketing and exploitation of genetically-modified organisms. Europe must not be left behind the USA and Japan. This, however, does not mean that we should overlook the safety issues surrounding these innovative applications, such as public health safety and environmental protection. I must point out that we have all witnessed the ongoing war of words recently over the safety of genetically modified organisms. This has led to confusion amongst consumers and has resulted in their being unable to form a sound judgement on the benefits and dangers of biotechnology. We should therefore win consumer confidence and the way to do so is by improving safety standards. For example, we can build up public confidence by banning the creation or use of GMOs containing antibiotic-resistant genes and by providing agencies and the general public with detailed and objective information. Parliament called at first reading for amendments to be incorporated into this directive which cover the above two objectives, i.e. the creation of a useful framework of rules for the deliberate release and trade in GMOs, accompanied by safety measures for the protection of public health and the environment and information for the public and consumers. It is also important for provision to be made for the directive to be adjusted and amended in line with new developments resulting from the fast pace of change in biotechnology and its applications. In closing, I should like to dwell on one point which I stressed in the Committee on the Environment and which deserves our particular attention, and that is the issue of safety. We are awaiting a more general proposal from the Commission on product liability and safety. We must not overreact if we want this directive to promote and support such a promising sector."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph